Achieve Life Sciences, Inc. Share Price
NASDAQ: ACHVAchieve Life Sciences, Inc. Stock Performance
Achieve Life Sciences, Inc. Share Price Today
As of 29 October 2026, Achieve Life Sciences, Inc.'s share price is $6.86. The stock opened at $6.88, compared to its previous close of $6.91. During today's trading session, Achieve Life Sciences, Inc.'s share price traded between $6.69 and $6.96, with an average price of $6.83. Over the past 52 weeks, the stock has recorded a high of $8.61 and a low of $2.63. In terms of performance, Achieve Life Sciences, Inc.'s share price has risen by 56.62% over the last six months and is up 33.72% on a year-on-year basis.
Achieve Life Sciences, Inc. Share Price Chart
Achieve Life Sciences, Inc. Quarterly Profit & Loss
All figures in USD
Achieve Life Sciences, Inc. Annual Profit & Loss
All figures in USD
About Achieve Life Sciences, Inc.
Achieve Life Sciences Inc is a late-stage specialty pharmaceutical company focused on the world-wide development and commercialization of cytisinicline as a treatment for nicotine dependence. Its New Drug Application (NDA) for cytisinicline for smoking cessation in adults is supported by two completed Phase 3 studies and an open-label long-term safety study. It has also completed a Phase 2 study of cytisinicline in nicotine e-cigarette cessation, conducted an end-of-Phase 2 meeting with the FDA, and has received Breakthrough Therapy designation for the vaping cessation indication.
Achieve Life Sciences, Inc. Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Oct 2026 | $7.97 | $6.83 | -15.51% |
Sep 2026 | $7.92 | $8.09 | -1.04% |
Aug 2026 | $6.30 | $8.18 | +27.73% |
Jul 2026 | $6.60 | $6.40 | -2.14% |
Jun 2026 | $5.14 | $6.54 | +24.57% |
May 2026 | $4.28 | $5.25 | +19.86% |
Apr 2026 | $3.00 | $4.38 | +48.98% |
Mar 2026 | $4.55 | $2.94 | -35.60% |
Feb 2026 | $4.14 | $4.57 | +9.47% |
Jan 2026 | $4.83 | $4.17 | -16.27% |
Dec 2025 | $4.76 | $4.98 | +1.84% |
Nov 2025 | $5.19 | $4.89 | -4.68% |